HSBC Holdings’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

HSBC Holdings’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-70,207	Closed	-$1.19M	–	2188
2014 Q4	$1.19M	Buy	70,207 +8,450	+14%	+$119K	﹤0.01%	1271
2014 Q3	$736K	Buy	61,757 +87	+0.1%	+$594	﹤0.01%	1391
2014 Q2	$347K	Buy	61,670 +154	+0.3%	+$710	﹤0.01%	1569
2014 Q1	$226K	Buy	61,516 +1,516	+3%	+$5.78K	﹤0.01%	1600
2013 Q4	$202K	Hold	60,000	–	–	﹤0.01%	1634
2013 Q3	$254K	Hold	60,000	–	–	﹤0.01%	1542
2013 Q2	$276K	Buy	+60,000	New	+$206K	﹤0.01%	1354

HSBC Holdings's AVNR Position: Q1 2015 in Review

HSBC Holdings sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 70,207 shares — an estimated $1.19M sold.

HSBC Holdings first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $1.19M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

HSBC Holdings reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
HSBC Holdings sold 70,207 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $1.19M.
HSBC Holdings first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
HSBC Holdings's AVANIR PHARMACEUTICALS, INC CL A position peaked at $1.19M in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on HSBC Holdings's 13F filing for Q1 2015, filed 14 May 2015.